ACTINIUM PHARMACEUTICALS, INC. Payments for Repurchase of Warrants
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Payments for Repurchase of Warrants of $600.00 thousand as of 2017-08-02, per its 10-Q filed 2022-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfWarrants · last filed 2022-08-12
- 2017-08-02: Payments for Repurchase of Warrants $600.00K.
| Period end | Payments for Repurchase of Warrants |
|---|---|
| 2017-08-02 | $600.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |